Ligand validation:4XP9

CLR: CHOLESTEROL

CLR is a Ligand Of Interest in 4XP9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XP9_CLR_C_705	30%	45%	0.271	0.936	0.68	1.41	-	7	0	0	100%	1
4XP4_CLR_A_705	56%	49%	0.148	0.921	0.73	1.21	-	4	0	0	100%	1
4XPH_CLR_A_607	50%	51%	0.169	0.918	0.67	1.22	-	4	1	0	100%	1
4XP1_CLR_A_711	47%	40%	0.165	0.906	0.73	1.57	-	7	2	0	100%	1
6M2R_CLR_A_703	46%	38%	0.211	0.946	0.67	1.74	1	11	1	0	100%	1
7WLW_CLR_A_708	42%	37%	0.2	0.919	0.67	1.76	-	14	0	0	100%	1
5IU4_CLR_A_2405	98%	59%	0.055	0.977	0.71	0.86	-	-	1	0	100%	1
5IU7_CLR_A_2405	95%	59%	0.072	0.976	0.75	0.82	-	-	0	0	100%	1
5MZJ_CLR_A_2404	90%	54%	0.078	0.961	0.77	0.99	-	2	0	0	100%	1
5OLZ_CLR_A_1203	89%	53%	0.082	0.96	0.71	1.08	-	3	5	0	100%	1
1LRI_CLR_A_99	88%	37%	0.088	0.965	1.14	1.34	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.